Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in psychopathology in schizophrenia patients starting treatment with new-generation antipsychotics: therapeutic drug monitoring in a naturalistic treatment setting.
Kaufmann A, Wartelsteiner F, Yalcin-Siedentopf N, Baumgartner S, Biedermann F, Edlinger M, Kemmler G, Rettenbacher MA, Rissanen TT, Widschwendter CG, Zernig G, Fleischhacker WW, Hofer A. Kaufmann A, et al. Among authors: zernig g. Eur Neuropsychopharmacol. 2016 Apr;26(4):717-28. doi: 10.1016/j.euroneuro.2016.02.002. Epub 2016 Feb 8. Eur Neuropsychopharmacol. 2016. PMID: 26879690
Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
Yalcin-Siedentopf N, Wartelsteiner F, Kaufmann A, Biedermann F, Edlinger M, Kemmler G, Rettenbacher MA, Widschwendter CG, Zernig G, Fleischhacker WW, Hofer A. Yalcin-Siedentopf N, et al. Among authors: zernig g. Int J Neuropsychopharmacol. 2014 Dec 7;18(5):pyu091. doi: 10.1093/ijnp/pyu091. Int J Neuropsychopharmacol. 2014. PMID: 25522423 Free PMC article.
Corrigendum to "Changes in psychopathology in schizophrenia patients starting treatment with new-generation antipsychotics: therapeutic drug monitoring in a naturalistic treatment setting" [Eur. Neuropsychopharmacol. 26 (2016) 717-728].
Kaufmann A, Post F, Yalcin-Siedentopf N, Baumgartner S, Biedermann F, Edlinger M, Kemmler G, Rettenbacher MA, Widschwendter CG, Zernig G, Fleischhacker WW, Hofer A. Kaufmann A, et al. Among authors: zernig g. Eur Neuropsychopharmacol. 2020 Feb;31:162-163. doi: 10.1016/j.euroneuro.2019.12.108. Epub 2020 Jan 8. Eur Neuropsychopharmacol. 2020. PMID: 31924492 No abstract available.
Quetiapine cross reactivity with urine methadone immunoassays.
Widschwendter CG, Zernig G, Hofer A. Widschwendter CG, et al. Among authors: zernig g. Am J Psychiatry. 2007 Jan;164(1):172. doi: 10.1176/ajp.2007.164.1.172. Am J Psychiatry. 2007. PMID: 17202566 No abstract available.
Influence of age and gender on risperidone plasma concentrations.
Aichhorn W, Weiss U, Marksteiner J, Kemmler G, Walch T, Zernig G, Stelzig-Schoeler R, Stuppaeck C, Geretsegger C. Aichhorn W, et al. Among authors: zernig g. J Psychopharmacol. 2005 Jul;19(4):395-401. doi: 10.1177/0269881105053306. J Psychopharmacol. 2005. PMID: 15982995
135 results